Despite the recent tumult, our expert still believes that biotech’s long-term investment story remains compelling.
Some themes and sectors may shine if the economy shifts into the late cycle. Here are potential opportunities.
The reality behind some common misconceptions that may be keeping investors out of international stocks.
Viewpoints on the iPad
Get our latest articles, and manage your portfolio and deposit checks.